Related Experiment Video
Updated: Apr 20, 2026
10:12
Protein Misfolding Cyclic Amplification of Prions
Published on: November 7, 2012
20.3K
Protein misfolding cyclic amplification (PMCA): Current status and future directions
Paula Saá1, Larisa Cervenakova1
1Transmissible Diseases Department, American National Red Cross, Biomedical Services, Holland Laboratory, 15601 Crabbs Branch Way, Rockville, MD 20855, United States.
Virus Research
|December 3, 2014
Summary
Transmissible spongiform encephalopathies (TSEs), or prion diseases, are fatal neurological disorders. The protein misfolding cyclic amplification (PMCA) assay efficiently detects and amplifies misfolded prion protein (PrP(TSE)), aiding TSE research.
Area of Science:
- Neuroscience
- Biochemistry
- Infectious Diseases
Background:
- Transmissible spongiform encephalopathies (TSEs), known as prion diseases, are fatal neurological disorders.
- Unlike other neurodegenerative diseases, TSEs are infectious, involving the misfolding and transmission of prion protein (PrP(TSE)).
- Traditional cell culture and animal models for studying TSEs are time-consuming and costly.
Purpose of the Study:
- To discuss the applications of protein misfolding cyclic amplification (PMCA) technology in studying TSEs.
- To highlight PMCA's ability to amplify and detect misfolded prion protein (PrP(TSE)).
- To explore PMCA's utility in understanding prion disease transmission and its adaptation for other neurodegenerative diseases.
Main Methods:
- Protein misfolding cyclic amplification (PMCA) assay.
- Cell-free conversion assays, including Quaking Induced Conversion (QuIC).
- Biochemical and biological characterization of amplified PrP(TSE).
Main Results:
- PMCA is the only technology demonstrated to generate infectious prions in vitro.
- PMCA allows indefinite amplification of PrP(TSE) while preserving strain-specific properties.
- PMCA can detect minute quantities of PrP(TSE) in various tissues and fluids, even pre-clinically.
- PMCA has been adapted to detect other amyloidogenic proteins implicated in neurodegenerative diseases.
Conclusions:
- PMCA offers a rapid, cost-effective alternative for TSE research.
- PMCA technology is crucial for understanding prion disease mechanisms, transmission, and diagnostics.
- The adaptability of PMCA extends its utility to the study of a broader range of neurodegenerative conformational disorders.
Related Concept Videos
03:03Amyloid Fibrils
13.2K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
13.2K
01:16Calmodulin-dependent Signaling
7.2K
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
7.2K